jueves, 3 de septiembre de 2026

Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial Therapy had shown potential in earlier trials, raising hopes for families

https://www.statnews.com/2026/09/02/ultragenyx-drug-angelman-syndrome-clinical-trial/ By Jason MastSept. 2, 2026 General Assignment Reporter

No hay comentarios:

Publicar un comentario